Pak Army arranges three-day visit for youth in Islamabad radio.gov.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from radio.gov.pk Daily Mail and Mail on Sunday newspapers.
Eli Lilly reported its phase 3 clinical trial data that showed showed significant reduction in sleep apnea symptoms in people who take Zepbound or Mounjaro.
A new clinical trial from drugmaker Eli Lilly shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms. Tirzepatide, the main ingredient in these medications, reduced symptom severity by nearly two-thirds. Around 20% of participants taking tirzepatide experienced weight loss.